Cargando…
Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac
Present technologies for wastewater treatment do not sufficiently address the increasing pollution situation of receiving water bodies, especially with the growing use of personal care products and pharmaceuticals (PPCP) in the private household and health sector. The relevance of addressing this pr...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912981/ https://www.ncbi.nlm.nih.gov/pubmed/27023823 http://dx.doi.org/10.1007/s11356-016-6503-x |
_version_ | 1782438343339933696 |
---|---|
author | Schröder, P. Helmreich, B. Škrbić, B. Carballa, M. Papa, M. Pastore, C. Emre, Z. Oehmen, A. Langenhoff, A. Molinos, M. Dvarioniene, J. Huber, C. Tsagarakis, K. P. Martinez-Lopez, E. Pagano, S. Meric Vogelsang, C. Mascolo, G. |
author_facet | Schröder, P. Helmreich, B. Škrbić, B. Carballa, M. Papa, M. Pastore, C. Emre, Z. Oehmen, A. Langenhoff, A. Molinos, M. Dvarioniene, J. Huber, C. Tsagarakis, K. P. Martinez-Lopez, E. Pagano, S. Meric Vogelsang, C. Mascolo, G. |
author_sort | Schröder, P. |
collection | PubMed |
description | Present technologies for wastewater treatment do not sufficiently address the increasing pollution situation of receiving water bodies, especially with the growing use of personal care products and pharmaceuticals (PPCP) in the private household and health sector. The relevance of addressing this problem of organic pollutants was taken into account by the Directive 2013/39/EU that introduced (i) the quality evaluation of aquatic compartments, (ii) the polluter pays principle, (iii) the need for innovative and affordable wastewater treatment technologies, and (iv) the identification of pollution causes including a list of principal compounds to be monitored. In addition, a watch list of 10 other substances was recently defined by Decision 2015/495 on March 20, 2015. This list contains, among several recalcitrant chemicals, the painkiller diclofenac and the hormones 17β-estradiol and 17α-ethinylestradiol. Although some modern approaches for their removal exist, such as advanced oxidation processes (AOPs), retrofitting most wastewater treatment plants with AOPs will not be acceptable as consistent investment at reasonable operational cost. Additionally, by-product and transformation product formation has to be considered. The same is true for membrane-based technologies (nanofiltration, reversed osmosis) despite of the incredible progress that has been made during recent years, because these systems lead to higher operation costs (mainly due to higher energy consumption) so that the majority of communities will not easily accept them. Advanced technologies in wastewater treatment like membrane bioreactors (MBR) that integrate biological degradation of organic matter with membrane filtration have proven a more complete elimination of emerging pollutants in a rather cost- and labor-intensive technology. Still, most of the presently applied methods are incapable of removing critical compounds completely. In this opinion paper, the state of the art of European WWTPs is reflected, and capacities of single methods are described. Furthermore, the need for analytical standards, risk assessment, and economic planning is stressed. The survey results in the conclusion that combinations of different conventional and advanced technologies including biological and plant-based strategies seem to be most promising to solve the burning problem of polluting our environment with hazardous emerging xenobiotics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11356-016-6503-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4912981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-49129812016-07-06 Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac Schröder, P. Helmreich, B. Škrbić, B. Carballa, M. Papa, M. Pastore, C. Emre, Z. Oehmen, A. Langenhoff, A. Molinos, M. Dvarioniene, J. Huber, C. Tsagarakis, K. P. Martinez-Lopez, E. Pagano, S. Meric Vogelsang, C. Mascolo, G. Environ Sci Pollut Res Int Review Article Present technologies for wastewater treatment do not sufficiently address the increasing pollution situation of receiving water bodies, especially with the growing use of personal care products and pharmaceuticals (PPCP) in the private household and health sector. The relevance of addressing this problem of organic pollutants was taken into account by the Directive 2013/39/EU that introduced (i) the quality evaluation of aquatic compartments, (ii) the polluter pays principle, (iii) the need for innovative and affordable wastewater treatment technologies, and (iv) the identification of pollution causes including a list of principal compounds to be monitored. In addition, a watch list of 10 other substances was recently defined by Decision 2015/495 on March 20, 2015. This list contains, among several recalcitrant chemicals, the painkiller diclofenac and the hormones 17β-estradiol and 17α-ethinylestradiol. Although some modern approaches for their removal exist, such as advanced oxidation processes (AOPs), retrofitting most wastewater treatment plants with AOPs will not be acceptable as consistent investment at reasonable operational cost. Additionally, by-product and transformation product formation has to be considered. The same is true for membrane-based technologies (nanofiltration, reversed osmosis) despite of the incredible progress that has been made during recent years, because these systems lead to higher operation costs (mainly due to higher energy consumption) so that the majority of communities will not easily accept them. Advanced technologies in wastewater treatment like membrane bioreactors (MBR) that integrate biological degradation of organic matter with membrane filtration have proven a more complete elimination of emerging pollutants in a rather cost- and labor-intensive technology. Still, most of the presently applied methods are incapable of removing critical compounds completely. In this opinion paper, the state of the art of European WWTPs is reflected, and capacities of single methods are described. Furthermore, the need for analytical standards, risk assessment, and economic planning is stressed. The survey results in the conclusion that combinations of different conventional and advanced technologies including biological and plant-based strategies seem to be most promising to solve the burning problem of polluting our environment with hazardous emerging xenobiotics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11356-016-6503-x) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-03-29 2016 /pmc/articles/PMC4912981/ /pubmed/27023823 http://dx.doi.org/10.1007/s11356-016-6503-x Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Article Schröder, P. Helmreich, B. Škrbić, B. Carballa, M. Papa, M. Pastore, C. Emre, Z. Oehmen, A. Langenhoff, A. Molinos, M. Dvarioniene, J. Huber, C. Tsagarakis, K. P. Martinez-Lopez, E. Pagano, S. Meric Vogelsang, C. Mascolo, G. Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac |
title | Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac |
title_full | Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac |
title_fullStr | Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac |
title_full_unstemmed | Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac |
title_short | Status of hormones and painkillers in wastewater effluents across several European states—considerations for the EU watch list concerning estradiols and diclofenac |
title_sort | status of hormones and painkillers in wastewater effluents across several european states—considerations for the eu watch list concerning estradiols and diclofenac |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912981/ https://www.ncbi.nlm.nih.gov/pubmed/27023823 http://dx.doi.org/10.1007/s11356-016-6503-x |
work_keys_str_mv | AT schroderp statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT helmreichb statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT skrbicb statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT carballam statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT papam statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT pastorec statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT emrez statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT oehmena statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT langenhoffa statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT molinosm statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT dvarionienej statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT huberc statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT tsagarakiskp statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT martinezlopeze statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT paganosmeric statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT vogelsangc statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac AT mascolog statusofhormonesandpainkillersinwastewatereffluentsacrossseveraleuropeanstatesconsiderationsfortheeuwatchlistconcerningestradiolsanddiclofenac |